A high-profile Canadian urologist received an editorial expression of concern for one of his papers this month, after anonymous comments on PubPeer flagged suspected data duplication in dozens of his articles.
By our count, sleuths have flagged 30 papers co-authored by Martin Gleave, a professor at the University of British Columbia in Canada and co-founder of the Vancouver Prostate Centre. According to the posts on PubPeer, images in these studies appear “much more similar than expected” based on analyses using the similarity detection software ImageTwin. The issues include similarities within individual papers and across multiple publications, with some comments suggesting the alleged reuse of tumor specimens.
Gleave, an appointee to the Order of Canada for his work developing treatments for prostate cancer, has received more than $120 million (approximately $84 million USD) in funding throughout his career, according to his profile on the Vancouver Prostate Centre website. He is also a co-founder of OncoGenex Pharmaceuticals, with several of the findings from the flagged papers connected to the company and related patents.
Continue reading Journals investigating dozens of papers by leading Canadian urologists